CDH Fund VI

Managed by CDH Investments

Overview

CDH Fund VI is part of CDH Investments’ private equity platform, which focuses on buyouts and investments in larger companies. The platform emphasizes opportunities in consumer, life sciences and healthcare, hard technology, and enterprise services and new infrastructure in China. The fund has invested in Sinovac Biotech.

Founded in 2002, CDH Investments is a China-focused alternative asset manager whose activities have expanded into Southeast Asia. Its platform includes private equity, venture and growth capital, private credit, public equities, and real assets. CDH’s private equity strategy focuses on buyouts and larger-company investments. The manager applies a value-oriented approach, works with portfolio companies over the long term, and draws on experience in complex transactions and merger integration.

Selected investments

  • Sinovac Biotech — Biopharmaceutical company.

Acquire an interest in CDH Fund VI

You might be able to acquire a position in CDH Fund VI. Sign up to explore available positions.

Gauge buyer interest for CDH Fund VI

Sign up here to anonymously gauge interest in your CDH Fund VI position.

Do you manage this fund? Get in touch to edit the text here.